Advanced Oncotherapy raises another £1.47m as it advances 'LIGHT' system
19th Aug 2022 11:48
(Sharecast News) - Proton therapy developer Advanced Oncotherapy announced it was raising £1.47m through a direct subscription on Friday, to fund its corporate activities as it moves its 'LIGHT' system towards full operation.
Read moreAdvanced Oncotherapy raises £2m for proton therapy development
25th Mar 2022 13:18
(Sharecast News) - Proton therapy technology developer Advanced Oncotherapy announced an equity fundraise of £2m on Friday, to fund itself along its revised timetable for the development of the 'LIGHT' cancer therapy system.
Read moreAdvanced Oncotherapy demonstrates 'potential superiority' of LIGHT system
12th Mar 2021 09:19
(Sharecast News) - Advanced Oncotherapy said on Friday that it has demonstrated the "potential capability and superiority" of its 'LIGHT' cancer proton therapy treatment systems to treat resistant cancers.
Read moreAdvanced Oncotherapy reaches deal with Birmingham NHS trust
20th Feb 2020 15:51
(Sharecast News) - Proton therapy developer Advanced Oncotherapy has reached agreement with University Hospitals Birmingham NHS Foundation Trust (UHB), the acute service provider delivering general hospital services for Birmingham and specialist treatments for the West Midlands and nationally, to install a 'LIGHT' system, it announced on Thursday.
Read moreAdvanced Oncotherapy agrees to install LIGHT system in Cyprus
17th Feb 2020 14:51
(Sharecast News) - Proton therapy systems developer Advanced Oncotherapy announced on Monday that the Mediterranean Hospital of Limassol in Cyprus has agreed to purchase a 'LIGHT' system for €50m.
Read moreAdvanced Oncotherapy strikes deal with The London Clinic
11th Feb 2020 15:40
(Sharecast News) - Proton therapy cancer treatment company Advanced Oncotherapy announced a memorandum of understanding with The London Clinic on Tuesday, to operate its first commercial 'LIGHT' facility on Harley Street in London.
Read moreAdvanced Oncotherapy secures £12.35m through loan and subscription
10th May 2019 13:12
(Sharecast News) - Proton therapy developer Advanced Oncotherapy has secured additional financing of £12.345m in the form of a two-year secured debt facility with Credit Suisse for £10m, and a direct subscription raising a total of £2.345m from predominantly Swiss institutional investors, it announced on Friday.
Read moreAdvanced Oncotherapy looks to collect £10m in DNCA-backed fundraiser
21st Dec 2018 10:40
(Sharecast News) - Cancer therapy developer Advanced Oncotherapy said it would issue 25m new ordinary shares at 40p each through direct subscription aimed at raising £10m.
Read moreAdvanced Oncotherapy gets planning permission for Harley St site
19th Oct 2016 09:56
(ShareCast News) - AIM-listed Advanced Oncotherapy has been granted planning permission by Westminster Council for a proton beam facility on Harley Street. The company, which develops next-generation proton therapy systems for cancer treatment, said the facility will make an important contribution t
Read moreAdvanced Oncotherapy raises £10m to fund first proton clinic in London
30th Sep 2016 10:34
(ShareCast News) - AIM-listed Advanced Oncotherapy raised £10m from a share placing to fund the development of the first proton therapy centre in London. The company raised the funds through the issue of 10m shares of 25p each to a new price of 100p per share to new and existing shareholders. The co
Read moreAdvanced Oncotherapy appoints Richard Amos as medical physics director
6th Sep 2016 11:38
(ShareCast News) - Developer of next-generation proton therapy systems for cancer treatment, Advanced Oncotherapy, announced on Tuesday that it has appointed Richard Amos as international director of medical physics, a non-board position, with effect from 1 November. The AIM-traded firm said Amos wa
Read moreAdvanced Oncotherapy makes good progress on LIGHT system; FY loss widens
31st May 2016 14:48
(ShareCast News) - Cancer treatment developer Advanced Oncotherapy said it had made good full year progress in developing its 'LIGHT' system, although losses for the full year widened. The company's Geneva-based development team is working on a proprietary proton accelerator called Linac Image Guide
Read moreAdvanced Oncotherapy in £24 million investment agreement
26th May 2016 13:35
(ShareCast News) - Advanced Oncotherapy has signed a £24m investment agreement with a fund advised by Metric Capital Partners LLP, pushing its shares up more than 7%. Metric Capital will invest the money in a financing facility to support Advanced Oncotherapy's provision of vendor financing for the
Read moreAdvanced Oncotherapy proton therapy programme progressing well
29th Mar 2016 16:44
(ShareCast News) - Advanced Oncotherapy was moving closer to success with its proton therapy for cancer treatment, updating the market on Tuesday of progress with its proton accelerator programme, dubbed 'LIGHT'. The AIM-traded company said its proton source, which was being constructed by Pantechni
Read moreAdvanced Oncotherapy reshuffles executive roles
8th Feb 2016 07:59
(ShareCast News) - Advanced Oncotherapy has reorganised its executive roles as it focuses on operational functions as well as ongoing sales and business development. The AIM-listed company said its executive chairman Michael Sinclair will have his role expanded to include chief executive officer, wh
Read more